Company Filing History:
3 out of 37 
1 out of 61 
Years Active: 2021-2024
Title: Ute Schaeper: A Pioneer in Genetic Innovation
Introduction
Ute Schaeper, based in Berlin, Germany, is a notable inventor recognized for her contributions to the field of genetics. With three patents to her name, her work focuses on innovative therapeutic approaches targeting specific gene expressions.
Latest Patents
Schaeper's latest inventions include:
1. **Nucleic acids for inhibiting expression of TMPRSS6 and iron chelators** - This patent encompasses compositions that utilize nucleic acid products to interfere with the TMPRSS6 gene expression. The invention aims at therapeutic applications for treating conditions such as hemochromatosis, porphyria, and blood disorders, including beta-thalassemia and sickle cell disease, as well as targeting infections related to bone marrow transplantation.
2. **Nucleic acids for inhibiting expression of PROS1 in a cell** - This patent focuses on nucleic acid products that inhibit PROS1 gene expression, exploring therapeutic uses of PROS1 inhibition for treating various bleeding disorders.
Career Highlights
Throughout her career, Ute Schaeper has made significant strides in genetic research. She has been affiliated with Silence Therapeutics GmbH, where she has leveraged her expertise to advance innovative therapeutic strategies. Additionally, she has worked at the University of Bern, which is known for its research-focused environment that complements her inventive activities.
Collaborations
In her professional journey, Schaeper has collaborated with esteemed colleagues, including Sibylle Dames and Judith Hauptmann. Their cooperation not only reflects a strong professional network but also highlights the collaborative nature of scientific research and invention.
Conclusion
Ute Schaeper stands out as a highly influential figure in the realm of genetic innovation. With her groundbreaking patents, she continues to pave the way for new treatments and contributes significantly to the understanding and management of genetic disorders. Her work exemplifies the transformative power of innovation in healthcare and therapeutic development.